Avadel Pharmaceuticals Plc (AVDL)

21.36 -0.03 (-0.14%) USD  |  NASDAQ  |  Dec 12, 16:00
21.63 +0.27 (+1.26%) After-Hours: 20:00
More

Avadel Pharmaceuticals Research and Development Expense (TTM): 39.89M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for AVDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Alkermes Plc 283.30M
Jazz Pharmaceuticals Plc 809.33M
Amarin Corp. Plc 17.36M
Perrigo Co. Plc 101.50M
Arcturus Therapeutics Holdings, Inc. 101.81M